gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 08 Dec 2016.

Family with sequence similarity 175, member A

Papers on CCDC98
Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions.
Winqvist et al., Oulu, Finland. In Sci Transl Med, 2012
The recurrent Abraxas c.1082G>A mutation connects to breast cancer predisposition.
Tubulin, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapy.
Schellens et al., Amsterdam, Netherlands. In Lung Cancer, 2011
low expression correlates with better response to chemotherapy and longer survival in patients with advanced non small-cell lung cancer
Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases.
Tischkowitz et al., Montréal, Canada. In Breast Cancer Res Treat, 2009
it seems unlikely that moderate to highly penetrant alleles of either RAP80 or Abraxas, confer a significantly high relative risk of breast cancer.
Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility.
Benítez et al., Madrid, Spain. In Breast Cancer Res Treat, 2009
Mutational analysis in 168 multiple-case breast/ovarian cancer families, negative for mutations in BRCA1 or BRCA2, suggests that CCDC98 does not play an important role as a high penetrance breast cancer susceptibility gene.
Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.
Taron et al., Badalona, Spain. In Plos One, 2008
examined RAP80 and Abraxas expression and their effect on treatment outcome in non-small-cell lung cancer
share on facebooktweetadd +1mail to friends